Ysardine, your last sentence was condescending balderdash....

Ysardine, your last sentence was condescending balderdash. Clearly, when we detect problems in life, if we are to solve them, we need to come up with a solution. I would not be involved in a spill of the BOD unless I, or another shareholder/s had replacements lined up for the deadwood. My best bet for a solution is a biotech specialist funded by private capital. Unfortunately, I do not know of any in Australia, and am not remotely in a position to talk to US or European players, however, it is quite possible that others will. Many of us are sick of being taken for a ride by Paul Hopper, and now have considerable doubt about his capacity to deliver. He of course can deliver for himself; at a quick glance, he is paying himself the best part of a $Million annually from the 3 ASX listed biotechs that he is 'employed' by. None of these companies pay dividends, and the capital losses that many investors are experiencing are woeful.